Peter Gebhardt

1.2k total citations
38 papers, 876 citations indexed

About

Peter Gebhardt is a scholar working on Molecular Biology, Pharmacology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Peter Gebhardt has authored 38 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Pharmacology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Peter Gebhardt's work include Medical Imaging Techniques and Applications (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Microbial Natural Products and Biosynthesis (5 papers). Peter Gebhardt is often cited by papers focused on Medical Imaging Techniques and Applications (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Microbial Natural Products and Biosynthesis (5 papers). Peter Gebhardt collaborates with scholars based in Germany, United States and Netherlands. Peter Gebhardt's co-authors include Robert Winkler, Hans Peter Saluz, Thorsten Heinekamp, Axel A. Brakhage, Olaf Kniemeyer, Helmar Görls, Reinald Fischer, Dirk Walther, Ute Möllmann and Thomas Opfermann and has published in prestigious journals such as Nature, Nature Communications and Applied and Environmental Microbiology.

In The Last Decade

Peter Gebhardt

34 papers receiving 842 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Gebhardt Germany 18 301 185 181 136 101 38 876
Tea Pavkov‐Keller Austria 24 969 3.2× 73 0.4× 169 0.9× 122 0.9× 30 0.3× 72 1.6k
Isabelle Parrot France 9 274 0.9× 77 0.4× 303 1.7× 122 0.9× 18 0.2× 12 1.7k
Megumi Tanaka Japan 17 169 0.6× 37 0.2× 74 0.4× 178 1.3× 43 0.4× 52 866
Louise Horsfall United Kingdom 17 493 1.6× 91 0.5× 161 0.9× 70 0.5× 50 0.5× 41 1.3k
Wenfeng Wang China 21 450 1.5× 101 0.5× 657 3.6× 128 0.9× 38 0.4× 81 1.6k
John A. Karas Australia 22 594 2.0× 149 0.8× 249 1.4× 59 0.4× 16 0.2× 52 1.2k
Ewa Krawczyk Poland 18 386 1.3× 27 0.1× 239 1.3× 61 0.4× 75 0.7× 84 1.2k
Mitsuhiro Ueda Japan 22 430 1.4× 66 0.4× 328 1.8× 255 1.9× 36 0.4× 95 1.4k
Manuele Martinelli Italy 17 844 2.8× 68 0.4× 53 0.3× 65 0.5× 98 1.0× 25 1.8k
Bernadette Bouchon France 20 745 2.5× 53 0.3× 135 0.7× 77 0.6× 84 0.8× 46 1.2k

Countries citing papers authored by Peter Gebhardt

Since Specialization
Citations

This map shows the geographic impact of Peter Gebhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Gebhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Gebhardt more than expected).

Fields of papers citing papers by Peter Gebhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Gebhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Gebhardt. The network helps show where Peter Gebhardt may publish in the future.

Co-authorship network of co-authors of Peter Gebhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Gebhardt. A scholar is included among the top collaborators of Peter Gebhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Gebhardt. Peter Gebhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Henriot, Véronique, et al.. (2024). Talin and vinculin combine their activities to trigger actin assembly. Nature Communications. 15(1). 9497–9497. 9 indexed citations
2.
Knerr, Julian, Ralf Werner, Carsten Schwan, et al.. (2023). Formin-mediated nuclear actin at androgen receptors promotes transcription. Nature. 617(7961). 616–622. 28 indexed citations
3.
Schulz, Volkmar, Peter Gebhardt, Teresa Nolte, et al.. (2020). Improving the Diagnosis of Breast Cancer using a dedicated PET/MRI – The EU Project HYPMED. Nuklearmedizin - NuclearMedicine. 4 indexed citations
4.
Gebhardt, Peter, et al.. (2019). A liquid phospholipid formulation of a curcumin extract with high concentration of phosphatidylcholine (Phosal® curcumin) improves the transport of curcuminoids across Caco-2 intestinal epithelial cells.. 30(4). 56–59. 1 indexed citations
5.
Gebhardt, Peter, et al.. (2014). Comparing 2-[18F]fluoro-2-deoxy-D-glucose and [68Ga]gallium-citrate translocation in Arabidopsis thaliana. Nuclear Medicine and Biology. 41(9). 737–743. 7 indexed citations
6.
Gebhardt, Peter, et al.. (2013). Dynamic behaviour of selected PET tracers in embryonated chicken eggs. Revista Española de Medicina Nuclear e Imagen Molecular. 32(6). 371–377. 19 indexed citations
8.
Opfermann, Thomas, et al.. (2012). Insights into Bone Metabolism of Avian Embryos In Ovo Via 3D and 4D 18F-fluoride Positron Emission Tomography. Molecular Imaging and Biology. 14(6). 688–698. 18 indexed citations
10.
Walther, Martin, Peter Gebhardt, Philipp Große-Gehling, et al.. (2011). Implementation of 89Zr production and in vivo imaging of B-cells in mice with 89Zr-labeled anti-B-cell antibodies by small animal PET/CT. Applied Radiation and Isotopes. 69(6). 852–857. 34 indexed citations
11.
Opfermann, Thomas, Peter Gebhardt, Mieczysław Gajda, et al.. (2010). In vivo molecular imaging of experimental joint inflammation by combined 18F-FDG positron emission tomography and computed tomography. Arthritis Research & Therapy. 12(6). R203–R203. 49 indexed citations
12.
Gebhardt, Peter, et al.. (2010). Computer controlled 68Ga milking and concentration system. Applied Radiation and Isotopes. 68(6). 1057–1059. 19 indexed citations
13.
Yang, Baiyuan, et al.. (2009). Preparation and biological evaluation of novel leucomycin analogs derived from nitroso Diels–Alder reactions. Organic & Biomolecular Chemistry. 8(3). 691–697. 13 indexed citations
15.
Gebhardt, Peter, K. Dornberger, Friedrich A. Gollmick, et al.. (2007). Quercinol, an anti-inflammatory chromene from the wood-rotting fungus Daedalea quercina (Oak Mazegill). Bioorganic & Medicinal Chemistry Letters. 17(9). 2558–2560. 51 indexed citations
16.
Gebhardt, Peter, et al.. (2006). An Unusual Reaction of the Natural Compound Benaphthamycin B:  Theoretical Study of a Model System. The Journal of Organic Chemistry. 71(3). 1074–1079. 2 indexed citations
17.
Reeves, Emer P., et al.. (2005). The expression of selected non-ribosomal peptide synthetases inAspergillus fumigatusis controlled by the availability of free iron. FEMS Microbiology Letters. 248(1). 83–91. 36 indexed citations
18.
Gebhardt, Peter, et al.. (2005). Semisynthetic preparation of leucomycin derivatives: Introduction of aromatic side chains by reductive amination. Molecular Diversity. 9(1-3). 27–32. 11 indexed citations
19.
Heinisch, Lothar, et al.. (2002). New synthetic catecholate-type siderophores with triamine backbone. BioMetals. 15(2). 133–144. 11 indexed citations
20.
Gebhardt, Peter. (1980). Literaturkritik und literarische Wertung. Wissenschaftliche Buchgesellschaft eBooks. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026